Appendix

Slide 39 - Diabetes Care - Overview

Slide 40 - Diabetes Care - Novo Nordisk's insulin market share

Slide 41 - IMS - Insulin World

Slide 42 - IMS - Insulin World

Slide 43 - Diabetes Care - Cartridge and Pre-filled device penetration

Slide 44 - Cartridge penetration (Incl. NovoLet®)

Slide 45 - Type 2 diabetes - Patient projections

Slide 46 - Expected growth of the Diabetes Care market

Slide 47 - Hormone Replacement Therapy - Overview

Slide 48 - Hormone Replacement Therapy - Novo Nordisk's market share of Systemic

Slide 49 - % of women aged 50-65 taking HRT in MAT Q3/98 

Slide 50 - Growth disorder - Overview

Slide 51 - Growth disorders - Novo Nordisk's hGH market share 

Slide 52 - Industrial enzyme producers

Slide 53 - Global market for industrial enzymes 1998

Slide 54 - Net turnover by business area

Slide 55 - Net financial items

Slide 56 - Cash flow 1998

Slide 57 - Capital expenditures 1998

Slide 58 - Capital expenditures 1999

Slide 59 - Financial results 1996-1998

  •  

Stock quotes:


Advanced
  •  
  •  

e-mail subscription

You can subscribe to our e-mail notification services.

Click here
  •